pSivida Corp. (PSDV) - Product Pipeline Analysis, 2015 Update

Date: October 14, 2015
Pages: 28
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: PD7BB10D01AEN
Leaflet:

Download PDF Leaflet

pSivida Corp. (PSDV) - Product Pipeline Analysis, 2015 Update
Summary

pSivida Corp. (pSivida) is a medical device company that provides miniaturized and sustained release drug delivery products. The company’s products include iluvien, retisert and durasert. Its durasert is an injectable, miniaturized, sustained-release drug delivery system, which is used for the treatment of chronic diseases of the back of the eye. pSivida’s iluvien is an injectable, non-erodible, intravitreal implant for the treatment of DME. The company’s retisert is an intravitreal drug implant for the treatment of chronic non-infectious posterior uveitis. The company has presence in the US and the UK. pSivida is headquartered in Watertown, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company pSivida Corp.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
pSivida Corp. Company Snapshot
pSivida Corp. Company Overview
Key Information
pSivida Corp. Pipeline Products and Clinical Trials Overview
pSivida Corp. – Pipeline Analysis Overview
Key Facts
pSivida Corp. - Major Products and Services
pSivida Corp. Pipeline Products by Development Stage
pSivida Corp. Clinical Trials by Trial Status
pSivida Corp. Pipeline Products Overview
Durasert Latanoprost Implant
Durasert Latanoprost Implant Product Overview
Medidur
Medidur Product Overview
Medidur Clinical Trial
Tethadur System
Tethadur System Product Overview
pSivida Corp. - Key Competitors
pSivida Corp. - Key Employees
pSivida Corp. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
pSivida Corp., Recent Developments
Sep 09, 2015: pSivida Provides Company Update and Reports Fourth Quarter and FY 2015 Results
Sep 03, 2015: pSivida CEO Invited to Speak at Surfaces in BioMaterials Foundation's BioInterface 2015 Annual Symposium
Jul 21, 2015: pSivida CEO to Speak at Controlled Release Society Annual Meeting Workshop in Edinburgh, Scotland, This Weekend
Jul 13, 2015: pSivida Announces Positive Top Line Results From Investigator-Sponsored Phase II Study of Medidur for Uveitis
Jun 24, 2015: pSivida CEO to Present at ISOPT Clinical Meeting in Berlin in July 2015
May 12, 2015: pSivida Announces Two Tech Evaluation Agreement s with Leading Global P harmaceutical Company
May 08, 2015: pSivida Reports Third Quarter FY 2015 Results
Feb 05, 2015: pSivida Reports Second Quarter FY 2015 Results
Nov 07, 2014: pSivida Reports First Quarter FY 2015 Results
Sep 10, 2014: pSivida Names James Barry to Board of Directors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

pSivida Corp., Key Facts
pSivida Corp. Pipeline Products and Clinical Trials Overview
pSivida Corp. Pipeline Products by Equipment Type
pSivida Corp. Pipeline Products by Indication
pSivida Corp. Clinical Trials by Trial Status
pSivida Corp., Key Facts
pSivida Corp., Major Products and Services
pSivida Corp. Number of Pipeline Products by Development Stage
pSivida Corp. Pipeline Products Summary by Development Stage
pSivida Corp. Clinical Trials by Trial Status
pSivida Corp. Clinical Trials Summary
Durasert Latanoprost Implant - Product Status
Durasert Latanoprost Implant - Product Description
Medidur - Product Status
Medidur - Product Description
Medidur - Phase I/II Study of pSivida’s Injectable Micro-insert in Patients with Posterior Uveitis
Medidur - Second Phase III Trial of Medidur for Posterior Uveitis in India
Tethadur System - Product Status
Tethadur System - Product Description
pSivida Corp., Key Employees
pSivida Corp., Other Locations
pSivida Corp., Subsidiaries

LIST OF FIGURES

pSivida Corp. Pipeline Products by Equipment Type
pSivida Corp. Pipeline Products by Development Stage
pSivida Corp. Clinical Trials by Trial Status
Skip to top


Ask Your Question

pSivida Corp. (PSDV) - Product Pipeline Analysis, 2015 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: